Prevalence of Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV) among Febrile Patients with Gastrointestinal Symptoms: A Prospective Study in A Tertiary Care Hospital
DOI:
https://doi.org/10.63682/jns.v14i11S.3428Keywords:
HAV, HEV, ELISA, Enteric Hepatotropic VirusesAbstract
Introduction: The prevalence of enteric hepatotropic viruses, such as hepatitis A virus (HAV) and hepatitis E virus (HEV), is influenced by the level of sanitation in a given area. Aim: This study aimed to determine the prevalence of HAV and HEV in febrile patients presenting with symptoms of diarrhoea and persistent vomiting. Methods: A prospective study was conducted at a tertiary care hospital, where 328 febrile patients were included. Blood samples were collected and serum was separated and analysed for specific HAV and HEV antibodies using ELISA (Enzyme Linked Immuosorbent Assay). Results: Out of 328 patients, tested for HAV IgM 24(7.3%) and HEV IgM 04(1.2%) were tested positive. The higher prevalence was observed in females than in males for both HAV and HEV infection, and the cases were eminent during monsoon season. Conclusion: The present study, underscores the importance of the early diagnosis to prevent the outbreaks in communities
Downloads
Metrics
References
Arankalle, V. A., Chadha, M. S., Chitambar, S. D., Walimbe, A. M., Chobe, L. P., & Gandhe, S. S. (2001). Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). Journal of Viral Hepatitis, 8(5), 293–303. https://doi.org/10.1046/j.1365-2893.2001.00370.x
Chatziprodromidou, I. P., Dimitrakopoulou, M. E., Apostolou, T., Katopodi, T., Charalambous, E., & Vantarakis, A. (2022). Hepatitis A and E in the Mediterranean: A systematic review. Travel Medicine and Infectious Disease, 50, 102283. https://doi.org/10.1016/j.tmaid.2022.102283
Sa-Nguanmoo, P., Posuwan, N., Vichaiwattana, P., Wutthiratkowit, N., Owatanapanich, S., Wasitthankasem, R., Thongmee, T., Poovorawan, K., Theamboonlers, A., Vongpunsawad, S., & Poovorawan, Y. (2015). Swine is a possible source of hepatitis E virus infection: A comparative study of hepatitis A and E seroprevalence in Thailand. PLoS ONE, 10(4), e0126184. https://doi.org/10.1371/journal.pone.0126184
Purcell, R. H., & Emerson, S. U. (2008). Hepatitis E: An emerging awareness of an old disease. Journal of Hepatology, 48(3), 494–503.
https://doi.org/10.1016/j.jhep.2007.12.008
World Health Organization. (n.d.). Hepatitis E. Retrieved from https://www.who.int/newsroom/fact-sheets/detail/hepatitis-e
Agrawal, M., Ruchi, K., Ashish, B., & Pallab, S. (2016). A study of seroprevalence and co-infection of hepatitis A and hepatitis E viruses in sporadic cases in an endemic area. Journal of Medical Sciences, 2(2), 45–50.
Hartard, C., Gantzer, C., Bronowicki, J. P., & Schvoerer, E. (2019). Emerging hepatitis E virus compared with hepatitis A virus: A new sanitary challenge. Reviews in Medical Virology, 29(1), e2078. https://doi.org/10.1002/rmv.2078
Palewar, M. S., Joshi, S., Choudhary, G., Das, R., Sadafale, A., & Karyakarte, R. (2022). Prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in patients presenting with acute viral hepatitis: A 3-year retrospective study at a tertiary care hospital in Western India. Journal of Family Medicine and Primary Care, 11(6), 2437–2441. https://doi.org/10.4103/jfmpc.jfmpc_327_22
Teshale, E. H., & Hu, D. J. (2011). Hepatitis E: Epidemiology and prevention. World Journal of Hepatology, 3(12), 285–291. https://doi.org/10.4254/wjh.v3.i12.285
Sherman, K. E., & Kottilil, S. (2017). Hepatitis A and E. In Schiff's Diseases of the Liver (pp. 563–583). Wiley.
Arora, N. K., Nanda, S. K., Gulati, S., Ansari, I. H., Chawla, M. K., Gupta, S. D., & Panda, S. K. (1996). Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. Journal of Medical Virology, 48(3), 215–221. https://doi.org/10.1002/(SICI)1096-9071
Dalton, H. R., Bendall, R., Ijaz, S., & Banks, M. (2008). Hepatitis E: An emerging infection in developed countries. The Lancet Infectious Diseases, 8(11), 698–709. https://doi.org/10.1016/S1473-3099(08)70255-X
Al-Naaimi, A. S., Turky, A. M., Khaleel, H. A., Jalil, R. W., Mekhlef, O. A., Kareem, S. A., Hasan, N. Y., & Dhadain, A. A. (2012). Predicting acute viral hepatitis serum markers (A and E) in patients with suspected acute viral hepatitis attending primary health care centers in Baghdad: A one-year cross-sectional study. Global Journal of Health Science, 4(1), 172–179. https://doi.org/10.5539/gjhs.v4n1p172
Khanna, R., Aggarwal, R., & Aggarwal, R. (2017). Hepatitis E: Epidemiology, disease burden, pathogenesis, and therapeutic strategies. Future Virology, 12(7), 343–358. https://doi.org/10.2217/fvl-2017-0018
Nayak, S., Acharjya, B., & Mohanty, S. (2019). Seroprevalence of hepatitis A and E virus infection in India: A systematic review and meta-analysis. Journal of Infection and Public Health, 12(5), 733–740. https://doi.org/10.1016/j.jiph.2019.01.069
Singh, J., Prakash, C., Gupta, R. S., Bora, D., Jain, D. C., & Datta, K. K. (1997). Epidemiology of endemic viral hepatitis in an urban area of India: A retrospective community study in Alwar. Bulletin of the World Health Organization, 75(5), 463–468.
Palewar, M. S., Joshi, S., Choudhary, G., Das, R., Sadafale, A., & Karyakarte, R. (2022). Prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in patients presenting with acute viral hepatitis: A 3-year retrospective study at a tertiary care hospital in Western India. Journal of Family Medicine and Primary Care, 11(6), 2437–2441. https://doi.org/10.4103/jfmpc.jfmpc_327_22
Mishra, B., Sharma, N., Singh, D., & Ratho, R. K. (2018). Co-infections in dengue patients: A systematic review. Journal of Infection and Public Health, 11(6), 725–730. https://doi.org/10.1016/j.jiph.2018.06.007
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
